NLRP3 antagonist 1

Overview

NLRP3 antagonist 1 is a potent antagonist of NLRP3 . NLRP3 is mainly expressed in macrophages and neutrophils and is involved in the body's intrinsic immunity against pathogenic infections and stress injury. NLRP3 antagonist 1 has the potential for the research of cancer disease (extracted from patent WO2021114691A1, compound 3).

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Depression | Products > Disease Areas > Autoimmune Disease | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer | Products > Signaling Pathways > NOD-like Receptor (NLR)

Product Information

• Catalog No.: HY-143563
• CAS No.: 2454017-83-3
• Molecular Formula: C16H18N6O
• Molecular Weight: 310.35
• Purity: 98.86%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.5 mg/mL (8.06 mM); Clear solution
• Availability: In-stock

Source

Original product source